Abstract:Intratumoral hypoxia significantly constrains the susceptibility of solid tumors to oxygen-dependent photodynamic therapy (PDT), and effort to reverse such hypoxia has achieved limited success to date. Herein, we developed a novel engineered bacterial system capable of targeting hypoxic tumor tissues and efficiently mediating the photodynamic treatment of these tumors. For this system, we genetically engineered Escherichia coli to express catalase, after which we explored an electrostatic adsorption approach to link black phosphorus quantum dots (BPQDs) to the surface of these bacteria, thereby generating an engineered E. coli/BPQDs (EB) system. Following intravenous injection, EB was able to target hypoxic tumor tissues. Subsequent 660 nm laser irradiation drove EB to generate reactive oxygen species (ROS) and destroy the membranes of these bacteria, leading to the release of catalase that subsequently degrades hydrogen peroxide to yield oxygen. Increased oxygen levels alleviate intratumoral hypoxia, thereby enhancing BPQD-mediated photodynamic therapy. This system was able to efficiently kill tumor cells in vivo, exhibiting good therapeutic efficacy. In summary, this study is the first to report the utilization of engineered bacteria to facilitate PDT, and our results highlight new avenues for BPQD-mediated cancer treatment.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c20254?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c20254</a>.Materials, methods, oxygen generation in 3% H2O2 solution after different bacteria lysis treatments as measured by a dissolved oxygen meter (Figure S1); AFM image of BPQDs (Figure S2); absorbance spectra of EB before and after rotation (Figure S3); height profiles of the BPQDs (Figure S4); CLSM photo of pure E. coli modified with DSPE-PEG-Cy5 (Figure S5); DCFH-DA fluorescence intensity (Figure S6); viability of E. coli survival rate (Figure S7); blood biochemistry data of kidney function markers: CRE and BUN (Figures S8 and S9); blood biochemistry data of liver function markers: ALT, ALP, and AST (Figure S10); histopathologic examination of tissues (Figure S11); and DCFH-DA fluorescence intensity (Figure S12) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c20254/suppl_file/am0c20254_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Engineered algae: A novel oxygen-generating system for effective treatment of hypoxic cancer

Calcium Phosphate Engineered Photosynthetic Microalgae to Combat Hypoxic-Tumor by In-Situ Modulating Hypoxia and Cascade Radio-Phototherapy.

Biomineralized Biohybrid-Algae for Tumor Hypoxia Modulation and Cascade Radio-Photodynamic Therapy.

Engineering micro oxygen factories to slow tumour progression via hyperoxic microenvironments

Engineered Oxygen Factories Synergize with STING Agonist to Remodel Tumor Microenvironment for Cancer Immunotherapy (Adv. Funct. Mater. 41/2023)

Engineered cyanobacteria-Fe3O4 hybrid system as oxygen generator and photosensitizer production factory for synergistic cancer PDT-immunotherapy

Surface-engineered chlorella alleviated hypoxic tumor microenvironment for enhanced chemotherapy and immunotherapy of first-line drugs

Novel Engineered Bacterium/Black Phosphorus Quantum Dot Hybrid System for Hypoxic Tumor Targeting and Efficient Photodynamic Therapy

Sonosynthetic Cyanobacteria Oxygenation for Self‐Enhanced Tumor‐Specific Treatment

Engineering tumor-oxygenated nanomaterials: advancing photodynamic therapy for cancer treatment

An oxygen self-sufficient NIR-responsive nanosystem for enhanced PDT and chemotherapy against hypoxic tumors

Engineered Microorganisms for Advancing Tumor Therapy

Hypoxic Tumor Radiosensitization Using Engineered Probiotics

A photo and tumor microenvironment activated nano-enzyme with enhanced ROS generation and hypoxia relief for efficient cancer therapy

A Biocompatible Free Radical Nanogenerator With Real-Time Monitoring Capability For High Performance Sequential Hypoxic Tumor Therapy

Fabrication of Hypoxia-Responsive and Uperconversion Nanoparticles-Modified RBC Micro-Vehicles for Oxygen Delivery and Chemotherapy Enhancement.

Microalgae-based Drug Delivery System for Tumor Microenvironment Photo-Modulating and Synergistic Chemo-Photodynamic Therapy of Osteosarcoma

Light-controlled oxygen production and collection for sustainable photodynamic therapy in tumor hypoxia

Cyanobacteria-based near-infrared light-excited self-supplying oxygen system for enhanced photodynamic therapy of hypoxic tumors

O 2 -Supplying Nanozymes Alleviate Hypoxia and Deplete Lactate to Eliminate Tumors and Activate Antitumor Immunity

Nanoparticles-mediated Reoxygenation Strategy Relieves Tumor Hypoxia for Enhanced Cancer Therapy